and diabetes, cerebral vascular accident as cause of death, serum creatinine level, hepatitis C status, and donation after cardiac death status. The KDPI approach replaced the prior designations of donor quality, standard criteria donor, and extended criteria donor (ECD).
Lower KDPI correlates with a better quality donor kidney, and estimated graft survival decreases as KDPI increases. 2 The four KDPI strata and their associated score ranges are sequences: A (≤20%), B (>20 but <35%), C (≥35 but ≤85%), or D (>85%). In an effort to optimize resource allocation by longevity matching, KAS allocates kidneys within the lowest KDPI stratum, sequence A, to patients with the highest estimated post-transplant survival, with the latter based on age, duration of dialysis, prior organ transplant, and diabetes status.
To increase utilization of more marginal kidneys and improve access through broader geographic sharing, kidneys within the highest KDPI stratum, sequence D (KDPI > 85), are allocated both locally and regionally from a single match run. However, recent data suggest that utilization of these organs actually decreased after the initial year of KAS implementation. 3 This finding may be attributable not only to decreased KDPI-based organ quality but also to increased cold ischemia time when organs are transported regionally as opposed to locally, with a subsequent decreased willingness of transplant programs to use them.
As KDPI is a relatively new concept, the literature evaluating this metric's relationship to long-term outcomes is sparse compared to the prior ECD designation. Although ECD kidneys have been associated with a 70% higher risk of graft failure, it has been proposed that the transplant-related increase in patient survival may be advantageous, especially for candidates over age 40 with longer wait times and diabetes. 4 Another study found no relative survival benefit for elderly recipients who received medium-quality versus lower quality kidneys. 5 Markov modeling estimates indicate that the KDPI-based allocation policy promotes increased quality-adjusted life years at lower lifetime costs of care through improved age and quality matching between recipients and donor organs. 
| MATERIALS AND METHODS

| Design and sample
Patient-reported longitudinal HRQOL data were collected at Vanderbilt University Medical Center in adult kidney transplant candidates and recipients under an IRB-approved protocol. A previously described survey battery was employed using a rolling enrollment process that maximizes the number of participants and follow-up duration by allowing persons to complete surveys at any monitoring point (pretransplant, at 1, 3, and 6 months, and annually after transplantation) regardless of whether they participated previously. 
| HRQOL measures
Health-related quality of life was measured using version 1 of the SF-36. 21 This extensively validated instrument, which is widely used in kidney transplant research, 22 Some study data were collected and managed using Research Electronic Data Capture (REDCap) tools hosted at Vanderbilt University Medical Center. REDCap is a secure, web-based application designed to support data capture for research studies. 24 Analyses were performed using IBM SPSS (version 24, Armonk, NY, USA) statistical software, and statistical significance was interpreted if a nondirectional P-value was <.05.
| RESULTS
The sample included 505 kidney transplant recipients transplanted between January 2006 and June 2014 and a cohort of 141 waitlisted candidates (Table 1) Median tests demonstrated no effect of high KDPI (>85, se- 
| DISCUSSION
Although kidney transplantation has been shown to be superior to dialysis in terms of survival and long-term costs of care, recent trends have shown increases in the number of waitlisted candidates while the organ supply remains unchanged. This imbalance has resulted in increased wait times and an increased number of patients removed from the waitlist due to death or a deteriorating medical condition.
Additionally, the number of waitlist candidates aged 65 years or older has risen from 13.8% in 2004 to 21.2% in 2014. 25 One proposed solution for this disparity has been to maximally utilize available organs, even those deemed of lower quality. In an effort to promote lower quality kidney utilization, the recently implemented KAS calculates organ quality based on KDPI, with lower quality having a higher number, and allocates them regionally initially in an effort to have more centers consider them for their patients.
Despite this goal to increase use of high KDPI kidneys, recent 1-year data after the KAS implementation report a 7.9% decrease in utilization of these organs from 939 organs to 904 in the year prior and the year following implementation, 3 and the reasons for this are likely multifactorial. Centers must now also accept a lower quality kidney as well as an increase in cold ischemia time for those organs transported regionally or nationally. Furthermore, cross-matches for compatibility often cannot be performed prior to the organ arrival, which increases the cold ischemia time of what is already considered a marginal organ. These organs are often being allocated to patients who would accept an organ of lower quality, such as the elderly or diabetics. Transplantation in these individuals has to be carefully weighed as cardiovascular events, infections, and malignancy occur disproportionately in elderly transplant recipients. 26, 27 In consideration of these negative outcomes, some transplanting physicians may choose not to utilize marginal organs under the assumption that the patient may not gain a substantial increase in survival or quality of life or that detriment to these may occur.
This is the first study to specifically evaluate the effect of donor organ quality, as reflected by KDPI sequence, on HRQOL after deceased donor kidney transplantation. We found that (i) increasing KDPI sequence does not adversely affect medium-term post-transplant HRQOL Strengths of this study include large sample sizes in two respects: that patient-reported HRQOL data were collected in over 500 recipients over up to 9 years and that these data encompassed over 5000 post-transplant time points. Additionally, the multivariable modeling methods accounted for factors that have previously been demonstrated to affect physical or mental HRQOL after solid organ transplantation including age, 16, 28, 29 gender, 16 rejection, and retransplantation. 29 Importantly, we interpret our data with respect to general population and clinical standards, which provide valuable reference points that augment statistical tests.
Limitations of our study include the limited sample size of the high KDPI (>85%) cohort, which included 16 patients, or 3% of the recipient sample. Although this is small, the overall national utilization of high KDPI kidneys was only 7.9% in the first year following KAS implemen- 
